InvestorsObserver
×
News Home

Do Analysts Agree Wednesday on Aspira Women's Health Inc (AWH) Stock's Target Price?

Wednesday, September 27, 2023 10:14 AM | InvestorsObserver Analysts

Mentioned in this article

Do Analysts Agree Wednesday on Aspira Women's Health Inc (AWH) Stock's Target Price?

Wall Street is positive on Aspira Women's Health Inc (AWH). On average, analysts give AWH a Buy rating. The average price target is $4.8, which means analysts expect the stock to decline by -11.76% over the next twelve months. That average ranking earns AWH an Analyst Rating of 26, which is better than 26% of stocks based on data compiled by InvestorsObserver.

Overall Score - 3.7
Wall Street analysts are rating AWH a Buy today. Find out what this means to you and get the rest of the rankings on AWH!

Why are Analyst Ratings Important?

A company's financial statements are a significant factor weighted by experts when analyzing a company's health. Beyond just the numbers, analysts follow specific industries closely and are able to gain a detailed understanding of how a storm in one part of the world can shutdown supply chains leading to a change in consumption across the globe. This knowledge allows investors to respond to potential changes in the market before they are revealed in a quarterly annoucement. InvestorsObserver averages the ratings across all these analysts and percentile ranks those averages. This allows you to compare stocks in greater detail than the usual five-tiered system used amongst the majority of investors.

What's Happening With Aspira Women's Health Inc Stock Today?

Aspira Women's Health Inc (AWH) stock is trading at $5.44 as of 10:14 AM on Wednesday, Sep 27, a rise of $0.08, or 1.53% from the previous closing price of $5.36. The stock has traded between $5.40 and $5.65 so far today. Volume today is below average. So far 8,773 shares have traded compared to average volume of 91,976 shares. Click Here to get the full Stock Report for Aspira Women's Health Inc stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App